Cashu FinanceCashu Finance
  • Terminal
  • Pulse
  • Spotlight
  • News
  • Cashu Research
Log inSign Up
← Back to Terminal
  1. Stocks
  2. Healthcare
  3. OTC
  4. SDZNY

Market Cap: $41.8B

SA

Sandoz Group AG

SDZNY
OTC (Other OTC)USD
Invest in SDZNY
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutive
Cashu FinanceCashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksScreenersAboutAuthorsAdvertisersBrokersConferencesContact

Legal

Terms of ServicePrivacy PolicyEditorial PolicyCorrections Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

$96.62
-$2.53(-2.55%)
At close: Nov 18, 16:24 EST

More on Sandoz Group AG

  • News & announcements
  • Financials

Sandoz Group AG at a Glance

  • Profitable, with a net margin of 5.6% over the last 12 months.

Open

$88.60

Prev. Close

$99.14

High

$88.60

Low

$86.86

Key Statistics

52-Week Range81% of range
Low $65.81High $103.98
Market Cap
$41.8B
P/E Ratio
66.32x
EPS (TTM)
$1.49
Revenue (TTM)
$11.62B
Dividend Yield
0.96%
Price / Book
4.76x
Beta
0.53
Avg. Volume
24.02K

Company Profile

Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.

CEORichard Saynor
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees23K
IPO DateOct 4, 2023
ExchangeOTC
Exchange NameOther OTC
CurrencyUSD
Headquarters & Contact
AddressCentralbahnstrasse 4
City / State / ZIPBasel, ZG, 4051
CountrySwitzerland
Phone

SDZNY Stock FAQ

What does Sandoz Group AG do?

Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities.

Where is Sandoz Group AG stock listed?

Sandoz Group AG trades on the Other OTC under the ticker SDZNY, priced in USD.

What is Sandoz Group AG's market cap?

Sandoz Group AG has a market capitalisation of $41.8B, based on its latest share price.

What is the P/E ratio of SDZNY?

SDZNY trades at 66.32 times its trailing 12-month earnings.

What is SDZNY's 52-week high and low?

Over the past 52 weeks SDZNY has traded between $65.81 and $103.98.

Does Sandoz Group AG pay a dividend?

Yes. Sandoz Group AG's dividend yields 0.96% at the current share price, paying out 67% of its earnings.

Is Sandoz Group AG profitable?

Profitable, with a net margin of 5.6% over the last 12 months.

What do analysts think of SDZNY stock?

The analyst consensus rating for SDZNY is Hold.

Who is the CEO of Sandoz Group AG?

Richard Saynor is the CEO of Sandoz Group AG, which is headquartered in Basel.

Shares trade 882% above a discounted cash flow (DCF) estimate of $9.84.
  • Moderate debt: borrowings are 0.69x shareholders' equity.
  • Strong Piotroski F-Score of 7/9, so fundamentals are improving.
  • Analyst consensus rating: Hold.
  • Pays a dividend yielding 0.96%, paying out 67% of earnings.
  • Generated automatically from reported financial data. General information only, not financial advice.

    Fundamentals Scorecard

    Each pillar is scored out of 5 from the latest reported data.

    • Valuation

      Weak · 2.0/5

      Price vs earnings, book value and discounted cash flow.

    • Profitability

      Fair · 3.5/5

      Return on equity and return on assets.

    • Financial Health

      Fair · 3.5/5

      Debt levels and Altman Z-Score bankruptcy risk.

    • Fundamental Trend

      Strong · 3.9/5

      Piotroski F-Score: 9 checks on profit, leverage and efficiency.

    See the full financial breakdown →
    41 61 324 11 11
    Websitehttps://www.sandoz.com